Literature DB >> 27995783

Review of global influenza activity, October 2015–October 2016.

.   

Abstract

Mesh：

Year:  2016        PMID： 27995783

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  5 in total

1.  Potential impact of B lineage mismatch on trivalent influenza vaccine effectiveness during the 2015-2016 influenza season among nursery school children in Suzhou, China.

Authors:  Yin Wang; Liling Chen; Yuejia Cheng; Suizan Zhou; Yuanyuan Pang; Jun Zhang; Carolyn M Greene; Ying Song; Tao Zhang; Genming Zhao
Journal:  Hum Vaccin Immunother       Date:  2017-12-06       Impact factor: 3.452

2.  Public health and economic impact of switching from a trivalent to a quadrivalent inactivated influenza vaccine in Mexico.

Authors:  Guillermo M Ruiz-Palacios; John H Beigel; Maria Lourdes Guerrero; Lucile Bellier; Ramiro Tamayo; Patricia Cervantes; Fabián P Alvarez; Arturo Galindo-Fraga; Felipe Aguilar-Ituarte; Juan Guillermo Lopez
Journal:  Hum Vaccin Immunother       Date:  2019-12-18       Impact factor: 3.452

3.  Cost-effectiveness of switching from trivalent to quadrivalent inactivated influenza vaccines for the at-risk population in Italy.

Authors:  Francesco Saverio Mennini; Chiara Bini; Andrea Marcellusi; Alessandro Rinaldi; Elisabetta Franco
Journal:  Hum Vaccin Immunother       Date:  2018-06-18       Impact factor: 3.452

4.  Influenza epidemiology and burden of disease in Mongolia, 2013-2014 to 2017-2018.

Authors:  Oyungerel Darmaa; Alexanderyn Burmaa; Baataryn Gantsooj; Badarchiin Darmaa; Pagbajabyn Nymadawa; Sheena G Sullivan; James E Fielding
Journal:  Western Pac Surveill Response J       Date:  2021-06-07

5.  Rapid risk assessment during the early weeks of the 2015-2016 influenza season in Ukraine.

Authors:  Sophie Newitt; Alla Mironenko; Olha Holubka; Oleksandr Zaika; Olga Gubar; Katri Jalava; Caroline Brown; Iryna Demchyshyna; Tetiana Dykhanovska
Journal:  Influenza Other Respir Viruses       Date:  2018-01-15       Impact factor: 4.380
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.